Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-013880
Filing Date
2023-04-27
Accepted
2023-04-27 17:26:34
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 299633
2 ex31-3.htm EX-31.3 4822
3 ex31-4.htm EX-31.4 4806
  Complete submission text file 0001493152-23-013880.txt   562696

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE invo-20221231.xsd EX-101.SCH 3245
5 XBRL LABEL FILE invo-20221231_lab.xml EX-101.LAB 36257
6 XBRL PRESENTATION FILE invo-20221231_pre.xml EX-101.PRE 23758
8 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7355
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

EIN.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39701 | Film No.: 23858620
SIC: 3841 Surgical & Medical Instruments & Apparatus